Pulmatrix, Inc. (PULM) DCF Valuation

Pulmatrix, Inc. (Pulm) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Pulmatrix, Inc. (PULM) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Pulmatrix, Inc. (PULM) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¿Busca evaluar el valor intrínseco de Pulmatrix, Inc.? Nuestra calculadora DCF (PULM) integra datos del mundo real con características de personalización integrales, lo que le permite ajustar preventos y mejorar sus estrategias de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 7.9 12.6 5.2 6.1 7.3 8.0 8.8 9.6 10.5 11.5
Revenue Growth, % 0 59.72 -59.09 17.45 20.21 9.57 9.57 9.57 9.57 9.57
EBITDA -13.2 -9.9 -15.4 -17.4 -13.3 -7.6 -8.4 -9.2 -10.1 -11.0
EBITDA, % -167.41 -78.06 -297.04 -286.64 -181.76 -95.61 -95.61 -95.61 -95.61 -95.61
Depreciation .8 1.0 1.2 1.5 1.5 1.4 1.5 1.7 1.8 2.0
Depreciation, % 9.67 8.26 23.91 25.45 20.21 17.5 17.5 17.5 17.5 17.5
EBIT -14.0 -10.9 -16.6 -18.9 -14.7 -7.8 -8.5 -9.3 -10.2 -11.2
EBIT, % -177.08 -86.31 -320.95 -312.09 -201.97 -97.26 -97.26 -97.26 -97.26 -97.26
Total Cash 23.4 31.7 53.8 35.6 19.2 8.0 8.8 9.6 10.5 11.5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 7.2 .1 .1 1.3 .9
Account Receivables, % 91.02 0.66487 1.3 21.38 12.72
Inventories .6 .7 .0 .2 .0 .2 .3 .3 .3 .3
Inventories, % 7.03 5.28 0.000019346102 2.52 0 2.97 2.97 2.97 2.97 2.97
Accounts Payable .6 .9 .8 1.2 1.9 1.2 1.3 1.5 1.6 1.8
Accounts Payable, % 7.59 6.74 16.23 19.57 26.24 15.27 15.27 15.27 15.27 15.27
Capital Expenditure -.1 -.3 -.1 -.1 -.7 -.3 -.3 -.3 -.3 -.4
Capital Expenditure, % -0.73325 -2.22 -2.79 -1.42 -9.26 -3.28 -3.28 -3.28 -3.28 -3.28
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -13.9 -16.1 -18.5 -18.8 -14.7 -7.8 -8.5 -9.3 -10.2 -11.2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -20.3 -8.1 -16.7 -18.4 -12.7 -8.7 -7.4 -8.1 -8.8 -9.7
WACC, % 7.83 7.84 7.84 7.84 7.84 7.84 7.84 7.84 7.84 7.84
PV UFCF
SUM PV UFCF -33.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -10
Terminal Value -169
Present Terminal Value -116
Enterprise Value -150
Net Debt -10
Equity Value -139
Diluted Shares Outstanding, MM 4
Equity Value Per Share -38.16

What You Will Get

  • Real PULM Financial Data: Pre-filled with Pulmatrix’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Pulmatrix’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Financial Inputs: Adjust essential metrics such as revenue projections, operating margins, and R&D expenses.
  • Instant DCF Valuation: Quickly computes intrinsic value, net present value, and additional financial metrics.
  • High-Precision Estimates: Leverages Pulmatrix's (PULM) actual financial data for accurate valuation results.
  • Streamlined Scenario Analysis: Easily explore various assumptions and evaluate different outcomes.
  • Efficiency Booster: Avoid the hassle of creating complex valuation models from the ground up.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based PULM DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other parameters.
  3. Instant Calculations: The model automatically refreshes Pulmatrix's intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Utilize the findings to inform your investment or financial strategy.

Why Choose This Calculator for Pulmatrix, Inc. (PULM)?

  • Designed for Experts: A sophisticated tool utilized by analysts, CFOs, and industry consultants.
  • Accurate Data: Pulmatrix’s historical and projected financials are preloaded for precise calculations.
  • Flexible Scenario Analysis: Easily simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance simplifies the entire process.

Who Should Use This Product?

  • Investors: Evaluate Pulmatrix’s valuation before making stock transactions.
  • CFOs and Financial Analysts: Optimize valuation workflows and assess financial forecasts.
  • Startup Founders: Understand the valuation methods applied to biotech companies like Pulmatrix.
  • Consultants: Provide detailed valuation reports for clients in the healthcare sector.
  • Students and Educators: Utilize real-life data to practice and teach valuation strategies.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Pulmatrix, Inc. (PULM) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Pulmatrix, Inc. (PULM).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.